Clinical Pathway and Monthly Feedback Improve Adherence to Antibiotic Guideline Recommendations for Community-Acquired Pneumonia

Background Compliance with community-acquired pneumonia (CAP) guidelines remains poor despite a substantial body of evidence indicating that guideline-concordant care improves patient outcomes. The aim of this study was to compare the relative effectiveness of a general educational and a targeted emergency department intervention on improving physicians’ concordance with CAP guidelines. Methods Two distinct interventions were implemented over specific time periods. The first intervention was educational, focusing on the development of local CAP guidelines and their dissemination through hospital-wide educational programmes. The second intervention was a targeted one for the emergency department, where a clinical pathway for the initial management of CAP patients was introduced, followed by monthly feedback to the emergency department (ED) physicians about concordance rates with the guidelines. Data on the concordance rate to CAP guidelines was collected from a retrospective chart review. Results A total of 398 eligible patient records were reviewed to measure concordance to CAP guidelines over the study period. Concordance rates during the baseline and educational intervention periods were similar (28.1% vs. 31.2%; p > 0.05). Significantly more patients were treated in accordance with the CAP guidelines after the ED focused intervention when compared to the baseline (61.5% vs. 28.1%; p < 0.05) or educational period (61.5% vs. 31.2%; p < 0.05). Conclusions A targeted intervention with a CAP clinical pathway and monthly feedback was a successful strategy to increase adherence to empirical antibiotic recommendations in CAP guidelines.

[1]  CORB is the best pneumonia severity score for elderly hospitalised patients with suspected pneumonia , 2014, Internal medicine journal.

[2]  S. Reeves,et al.  Implementation Science BioMed Central Debate , 2005 .

[3]  G. Peterson,et al.  Factors influencing ceftriaxone use in community‐acquired pneumonia: Emergency doctors’ perspectives , 2014, Emergency Medicine Australasia.

[4]  Peter J. Embi,et al.  Evaluating alert fatigue over time to EHR-based clinical trial alerts: findings from a randomized controlled study , 2012, J. Am. Medical Informatics Assoc..

[5]  T. File,et al.  Burden of Community-Acquired Pneumonia in North American Adults , 2010, Postgraduate medicine.

[6]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[7]  Sylvia J. Hysong,et al.  Meta-Analysis: Audit and Feedback Features Impact Effectiveness on Care Quality , 2009, Medical care.

[8]  S. Bowler,et al.  Effect of a simple educational intervention on the hospital management of community‐acquired pneumonia , 2007, Respirology.

[9]  C. Rees,et al.  A window into the lives of junior doctors: narrative interviews exploring antimicrobial prescribing experiences. , 2014, The Journal of antimicrobial chemotherapy.

[10]  S. Corrao,et al.  Can CAP guideline adherence improve patient outcome in internal medicine departments? , 2008, European Respiratory Journal.

[11]  Jacqueline A Pugh,et al.  Audit and feedback and clinical practice guideline adherence: Making feedback actionable , 2006, Implementation science : IS.

[12]  M. Ortega,et al.  Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  G. Peterson,et al.  Community‐acquired pneumonia: why aren't national antibiotic guidelines followed? , 2015, International journal of clinical practice.

[14]  M. Whitby,et al.  Poor compliance with community-acquired pneumonia antibiotic guidelines in a large Australian private hospital emergency department. , 2014, Microbial drug resistance.

[15]  T. Marrie,et al.  A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. , 2000, JAMA.

[16]  Michael J Fine,et al.  Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  Joshua S. Davis,et al.  Rocket science and the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines for severe community-acquired pneumonia. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  Kylie L Easton,et al.  Empiric management of community‐acquired pneumonia in Australian emergency departments , 2005, The Medical journal of Australia.

[20]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Rory Wolfe,et al.  SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Grimshaw,et al.  Printed educational materials: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[23]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[24]  W. Lim,et al.  BTS guidelines for the management of community acquired pneumonia in adults: update 2009 , 2009, Thorax.

[25]  A D Oxman,et al.  Educational outreach visits: effects on professional practice and health care outcomes. , 2007, The Cochrane database of systematic reviews.

[26]  S. Allen,et al.  From the Australian Commission on Safety and Quality in Health Care , 2011, The Medical journal of Australia.

[27]  Scot H Simpson,et al.  Do guidelines guide pneumonia practice? A systematic review of interventions and barriers to best practice in the management of community-acquired pneumonia. , 2005, Respiratory care clinics of North America.

[28]  R. Grol,et al.  Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: a qualitative study , 2007, Quality and Safety in Health Care.